131 related articles for article (PubMed ID: 10280287)
1. Aminoglycoside monitoring: use of a pharmacokinetic service versus physician recommendations.
Smith M; Murphy JE; Job ML; Ward ES
Hosp Formul; 1987 Jan; 22(1):92-9, 102. PubMed ID: 10280287
[TBL] [Abstract][Full Text] [Related]
2. Outcome of patients treated by an aminoglycoside pharmacokinetic dosing service.
Sveska KJ; Roffe BD; Solomon DK; Hoffmann RP
Am J Hosp Pharm; 1985 Nov; 42(11):2472-8. PubMed ID: 4073064
[TBL] [Abstract][Full Text] [Related]
3. Cost analysis of an aminoglycoside pharmacokinetic dosing program.
Schloemer JH; Zagozen JJ
Am J Hosp Pharm; 1984 Nov; 41(11):2347-51. PubMed ID: 6507436
[TBL] [Abstract][Full Text] [Related]
4. Establishing an aminoglycoside pharmacokinetic monitoring service in a community hospital.
Bollish SJ; Kelly WN; Miller DE; Timmons RG
Am J Hosp Pharm; 1981 Jan; 38(1):73-6. PubMed ID: 7211873
[TBL] [Abstract][Full Text] [Related]
5. A practical approach enabling staff pharmacists to prospectively review and dose aminoglycoside therapy.
Possidente CJ; Lynch T
Hosp Pharm; 1988 Nov; 23(11):976-8, 981-3. PubMed ID: 10290757
[TBL] [Abstract][Full Text] [Related]
6. Aminoglycoside dosing service provided by baccalaureate-level pharmacists.
Moore RA; Tonnies FE
Am J Hosp Pharm; 1984 Jan; 41(1):98-105. PubMed ID: 6695941
[TBL] [Abstract][Full Text] [Related]
7. Justification and evaluation of an aminoglycoside pharmacokinetic dosing service.
Jorgenson JA; Rewers RF
Hosp Pharm; 1991 Jul; 26(7):605, 609-11, 615. PubMed ID: 10111793
[TBL] [Abstract][Full Text] [Related]
8. A utilization and cost-benefit analysis of an aminoglycoside kinetics monitoring service.
Pinilla J; Shafran S; Conly J
Clin Invest Med; 1992 Feb; 15(1):8-17. PubMed ID: 1572110
[TBL] [Abstract][Full Text] [Related]
9. Physicians' perceptions of the effect of a pharmacokinetic service on their ability to independently function.
Lackner TE; Manchester R
Hosp Pharm; 1991 Jul; 26(7):618, 632. PubMed ID: 10111795
[TBL] [Abstract][Full Text] [Related]
10. Cost-benefit analysis of an aminoglycoside monitoring service.
Kimelblatt BJ; Bradbury K; Chodoff L; Aggour T; Mehl B
Am J Hosp Pharm; 1986 May; 43(5):1205-9. PubMed ID: 3087162
[TBL] [Abstract][Full Text] [Related]
11. Impact of an aminoglycoside kinetic service on aminoglycoside use in a community hospital.
Cahill RJ; Myers RM; Bauer LA; Alston RM
Hosp Pharm; 1986 Aug; 21(8):734-7. PubMed ID: 10277582
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of a pharmacy based aminoglycoside monitoring service.
Tierney MG; Braden LA
Can J Hosp Pharm; 1984; 37(4):135-6, 143. PubMed ID: 10269317
[TBL] [Abstract][Full Text] [Related]
13. Implementation of a once-daily aminoglycoside program in a large community-teaching hospital.
Nicolau DP; Belliveau PP; Nightingale CH; Quintiliani R; Freeman CD
Hosp Pharm; 1995 Aug; 30(8):674-6, 679-80. PubMed ID: 10144645
[TBL] [Abstract][Full Text] [Related]
14. Application of Bayes theorem to aminoglycoside-associated nephrotoxicity: comparison of extended-interval dosing, individualized pharmacokinetic monitoring, and multiple-daily dosing.
Kim MJ; Bertino JS; Erb TA; Jenkins PL; Nafziger AN
J Clin Pharmacol; 2004 Jul; 44(7):696-707. PubMed ID: 15199074
[TBL] [Abstract][Full Text] [Related]
15. Aminoglycoside monitoring program.
Vakoutis J; Stein GE; Miller PB; Clayman AE
Am J Hosp Pharm; 1981 Oct; 38(10):1477-80. PubMed ID: 7294041
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial drug use monitoring by a hospital pharmacy.
Greenlaw CW
Am J Hosp Pharm; 1977 Aug; 34(8):835-8. PubMed ID: 900135
[TBL] [Abstract][Full Text] [Related]
17. Multidisciplinary protocol for determining aminoglycoside dosage.
Lynch TJ; Possidente CJ; Cioffi WG; Hebert JC
Am J Hosp Pharm; 1992 Jan; 49(1):109-15. PubMed ID: 1570850
[TBL] [Abstract][Full Text] [Related]
18. Aminoglycoside utilization study.
Haslett TM; Reynolds JR
Hosp Pharm; 1988 Oct; 23(10):872, 874-5, 878-80. PubMed ID: 10290108
[TBL] [Abstract][Full Text] [Related]
19. Cost of individualizing aminoglycoside dosage regimens.
Bootman JL; Zaske DE; Wertheimer AI; Rowland C
Am J Hosp Pharm; 1979 Mar; 36(3):368-70. PubMed ID: 420232
[TBL] [Abstract][Full Text] [Related]
20. Minimizing aminoglycoside toxicity by prescriber notification of prolonged therapy.
Brown G
Hosp Pharm; 1995 Jan; 30(1):33-6. PubMed ID: 10139728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
